Hormonal Levels among HIV-1-Seropositive Women Compared with High-Risk HIV-Seronegative Women during the Menstrual Cycle
- 1 October 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Women's Health & Gender-Based Medicine
- Vol. 9 (8) , 857-863
- https://doi.org/10.1089/152460900750020883
Abstract
There is a paucity of normative data on hormonal levels among HIV-infected women. Hormonal levels may influence fertility and HIV-related immunological and virological factors. The objective of this study was to determine progesterone and estradiol levels during the menstrual cycle in HIV-seropositive women compared with high-risk seronegative women. The study enrolled 55 HIV-infected and 10 high-risk uninfected women with self-reported regular menstrual cycles (25-30-day cycles). Progesterone and estradiol levels were determined on a weekly basis for 8 weeks. The analysis included evaluations from the first complete menstrual cycle for the 54 HIV-infected and 9 uninfected women who had at least one complete cycle. The median age was 35 years for HIV-infected women and 36 years for uninfected women. The median CD4+ count for HIV-seropositive women was 210 cells/mm3. The median menstrual cycle length was 28 days (range 22-49 days) for HIV-infected women and 25 days (range 24-44 days) for uninfected women. The maximum progesterone level during the luteal phase was normal (> 3.0 ng/ml) for 52 (96%) of 54 HIV-seropositive women and 7 (78%) of 9 HIVseronegative women (p = 0.09, Fisher's exact test). The median maximum progesterone level was 12.2 ng/ml in HIV-seropositive women and 7.2 ng/ml in HIV-seronegative women (p = 0.07, Wilcoxon test). The median maximum estradiol value during the follicular phase was 148 pg/ml for HIV-seropositive women and 111 pg/ml for HIV-seronegative women (p = 0.04, Wilcoxon test). Among HIV-infected women, there were no significant differences in progesterone and estradiol levels by antiretroviral therapy, baseline plasma viral load, or median CD4+ cell count. We conclude that HIV-infected women with self-reported normal menstrual cycles have normal levels of progesterone and estradiol during the menstrual cycle.Keywords
This publication has 21 references indexed in Scilit:
- Impact of the Ovulatory Cycle on Virologic and Immunologic Markers in HIV‐Infected WomenThe Journal of Infectious Diseases, 2000
- Characteristics of menstruation in women infected with human immunodeficiency virusPublished by Wolters Kluwer Health ,1999
- Systematic review of hormonal contraception and risk of HIV transmissionAIDS, 1998
- Genetic Subtypes of HIV Type 1 and HIV Type 2 Strains in Commercial Sex Workers from Bamako, MaliAIDS Research and Human Retroviruses, 1998
- Interaction of Pregnancy Steroid Hormones and Zidovudine in Inhibition of HIV Type 1 Replication in Monocytoid and Placental Hofbauer Cells: Implications for the Prevention of Maternal-Fetal Transmission of HIVAIDS Research and Human Retroviruses, 1997
- Body Composition and Endocrine Function in Women with Acquired Immunodeficiency Syndrome WastingJournal of Clinical Endocrinology & Metabolism, 1997
- Human Immunodeficiency Virus in Plasma and Genital Secretions during the Menstrual CycleThe Journal of Infectious Diseases, 1996
- Menstrual Function in Human Immunodeficiency Virus-Infected Women Without Acquired Immunodeficiency SyndromeJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Pregnancy rates among women infected with human immunodeficiency virusObstetrics & Gynecology, 1996
- Regulatory Elements in the Human Immunodeficiency Virus Type 1 Long Terminal Repeat LTR(HIV-1) Responsive to Steroid Hormone StimulationAIDS Research and Human Retroviruses, 1992